CIMZIA

Welcome to the Brand page for “CIMZIA”, which is offered here for In the statement column 1, line 6 after of infectious diseases, cancer ophthal- should be deleted, lines 7, 8, 9, and 10 should be deleted; in line 11, graines, should be deleted.; line 11 after arthritis and should be inserted; and , pharmaceutical should be deleted; line 12, should be deleted; in line 13 trointestinal diseases should be deleted; lines 14, 15, 16, and 17 should be deleted; in the statement, column 2, lines 1, 2, 3, 4, 5, 6, should be deleted; in line 7, replacement therapy; analgesics; should be deleted.;pharmaceutical preparations, preparations for the treatment of [ infectious diseases, cancer, ophthalmologic conditions and diseases, central nervous systems diseases and disorders, parkinson's disease, cardiovascular diseases and conditions, migraines, ] arthritis, including but not limited to, ankylosing spondylitis, * and * [, pharmaceutical preparations for the treatment of gastrointestinal diseases, ] crohns disease; [, pharmaceutical preparations for the treatment and symptoms of diabetes, pharmaceutical preparations for urological use, pharmaceutical preparations for the treatment of urinary tract and bladder infections, gynecological preparations for the treatment of birth control, and for the treatment for endometriosis, hormonal preparations, hormone replacement therapy; analgesics; ] anti-inflammatory pharmaceutical preparations;.

Its status is currently believed to be active. Its class is unavailable. “CIMZIA” is believed to be currently owned by “UCB PHARMA, S.A.”